These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9808564

  • 41. Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor.
    Kallas A, Pooga M, Benhida A, Jacquemin M, Saint-Remy JM.
    Thromb Res; 2002 Sep 15; 107(6):291-302. PubMed ID: 12565716
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Mapping factor VIII inhibitor epitopes using hybrid human/porcine factor VIII molecules.
    Lollar P.
    Haematologica; 2000 Oct 15; 85(10 Suppl):26-8; discussion 28-30. PubMed ID: 11187866
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The C1 and C2 domains of blood coagulation factor VIII mediate its endocytosis by dendritic cells.
    Gangadharan B, Ing M, Delignat S, Peyron I, Teyssandier M, Kaveri SV, Lacroix-Desmazes S.
    Haematologica; 2017 Feb 15; 102(2):271-281. PubMed ID: 27758819
    [Abstract] [Full Text] [Related]

  • 48. Molecular characterization of human B domain-specific anti-factor VIII monoclonal antibodies generated in transgenic mice.
    Lavigne-Lissalde G, Lacroix-Desmazes S, Wootla B, Tarrade C, Schved JF, Kaveri SV, Granier C, Villard-Saussine S.
    Thromb Haemost; 2007 Jul 15; 98(1):138-47. PubMed ID: 17598006
    [Abstract] [Full Text] [Related]

  • 49. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
    Saenko EL, Scandella D.
    J Biol Chem; 1995 Jun 09; 270(23):13826-33. PubMed ID: 7775440
    [Abstract] [Full Text] [Related]

  • 50. Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor.
    Ronayne EK, Peters SC, Gish JS, Wilson C, Spencer HT, Doering CB, Lollar P, Spiegel PC, Childers KC.
    Front Immunol; 2021 Jun 09; 12():697602. PubMed ID: 34177966
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Immunoblot cross-reactivity of factor VIII inhibitors with porcine factor VIII.
    Koshihara K, Qian J, Lollar P, Hoyer LW.
    Blood; 1995 Sep 15; 86(6):2183-90. PubMed ID: 7662967
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.
    Lü J, Pipe SW, Miao H, Jacquemin M, Gilbert GE.
    Blood; 2011 Mar 17; 117(11):3181-9. PubMed ID: 21156843
    [Abstract] [Full Text] [Related]

  • 55. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S, Gaucher C, Piétu G, Chérel G, Meyer D, Mazurier C.
    Br J Haematol; 1994 May 17; 87(1):113-8. PubMed ID: 7524613
    [Abstract] [Full Text] [Related]

  • 56. Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors.
    Meeks SL, Healey JF, Parker ET, Barrow RT, Lollar P.
    Blood; 2008 Aug 15; 112(4):1151-3. PubMed ID: 18495957
    [Abstract] [Full Text] [Related]

  • 57. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH, Nakai H, Felch M, Mondorf W, Scharrer I, Hoyer LW, Saenko EL.
    Thromb Res; 2001 Mar 01; 101(5):377-85. PubMed ID: 11297754
    [Abstract] [Full Text] [Related]

  • 58. Highly conserved antigenic structure of the factor VIII C2 domain in some mammals.
    Ori J, Tanaka I, Kubota Y, Shima M, Matsumoto T, Yoshida K, Sakurai Y, Yoshioka A.
    Int J Hematol; 2005 Nov 01; 82(4):351-6. PubMed ID: 16298830
    [Abstract] [Full Text] [Related]

  • 59. The diversity of the immune response to the A2 domain of human factor VIII.
    Markovitz RC, Healey JF, Parker ET, Meeks SL, Lollar P.
    Blood; 2013 Apr 04; 121(14):2785-95. PubMed ID: 23349389
    [Abstract] [Full Text] [Related]

  • 60. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C, Schulz-Drost S, Khrenov AV, Saenko EL, Klinge J, Schneider H.
    Thromb Haemost; 2004 Mar 04; 91(3):619-25. PubMed ID: 14983240
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.